| Year |
Citation |
Score |
| 2014 |
Restrepo D, Hellier JL, Salcedo E. Complex metabolically demanding sensory processing in the olfactory system: implications for epilepsy. Epilepsy & Behavior : E&B. 38: 37-42. PMID 24113565 DOI: 10.1016/J.Yebeh.2013.08.036 |
0.452 |
|
| 2013 |
Diao L, Hellier JL, Uskert-Newsom J, Williams PA, Staley KJ, Yee AS. Diphenytoin, riluzole and lidocaine: three sodium channel blockers, with different mechanisms of action, decrease hippocampal epileptiform activity. Neuropharmacology. 73: 48-55. PMID 23707481 DOI: 10.1016/j.neuropharm.2013.04.057 |
0.579 |
|
| 2010 |
White A, Williams PA, Hellier JL, Clark S, Dudek FE, Staley KJ. EEG spike activity precedes epilepsy after kainate-induced status epilepticus. Epilepsia. 51: 371-83. PMID 19845739 DOI: 10.1111/J.1528-1167.2009.02339.X |
0.735 |
|
| 2009 |
Frey LC, Hellier J, Unkart C, Lepkin A, Howard A, Hasebroock K, Serkova N, Liang L, Patel M, Soltesz I, Staley K. A novel apparatus for lateral fluid percussion injury in the rat. Journal of Neuroscience Methods. 177: 267-72. PMID 19022291 DOI: 10.1016/j.jneumeth.2008.10.022 |
0.487 |
|
| 2009 |
Hellier JL, White A, Williams PA, Dudek FE, Staley KJ. NMDA receptor-mediated long-term alterations in epileptiform activity in experimental chronic epilepsy. Neuropharmacology. 56: 414-21. PMID 18930747 DOI: 10.1016/j.neuropharm.2008.09.009 |
0.704 |
|
| 2008 |
Jarrett SG, Liang LP, Hellier JL, Staley KJ, Patel M. Mitochondrial DNA damage and impaired base excision repair during epileptogenesis. Neurobiology of Disease. 30: 130-8. PMID 18295498 DOI: 10.1016/j.nbd.2007.12.009 |
0.548 |
|
| 2007 |
Williams PA, Hellier JL, White AM, Staley KJ, Dudek FE. Development of spontaneous seizures after experimental status epilepticus: implications for understanding epileptogenesis. Epilepsia. 48: 157-63. PMID 17910596 DOI: 10.1111/j.1528-1167.2007.01304.x |
0.736 |
|
| 2007 |
Hellier JL, Grosshans DR, Coultrap SJ, Jones JP, Dobelis P, Browning MD, Staley KJ. NMDA receptor trafficking at recurrent synapses stabilizes the state of the CA3 network. Journal of Neurophysiology. 98: 2818-26. PMID 17728388 DOI: 10.1152/Jn.00346.2007 |
0.533 |
|
| 2007 |
Swiercz W, Cios K, Hellier J, Yee A, Staley K. Effects of synaptic depression and recovery on synchronous network activity. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 24: 165-74. PMID 17414972 DOI: 10.1097/WNP.0b013e318033756f |
0.539 |
|
| 2005 |
Hellier JL, Dudek FE. Chemoconvulsant model of chronic spontaneous seizures. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.19. PMID 18428628 DOI: 10.1002/0471142301.ns0919s31 |
0.701 |
|
| 2005 |
Staley K, Hellier JL, Dudek FE. Do interictal spikes drive epileptogenesis? The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 11: 272-6. PMID 16061513 DOI: 10.1177/1073858405278239 |
0.741 |
|
| 2002 |
Dudek FE, Hellier JL, Williams PA, Ferraro DJ, Staley KJ. The course of cellular alterations associated with the development of spontaneous seizures after status epilepticus. Progress in Brain Research. 135: 53-65. PMID 12143370 DOI: 10.1016/S0079-6123(02)35007-6 |
0.745 |
|
| 2001 |
Staley KJ, Bains JS, Yee A, Hellier J, Longacher JM. Statistical model relating CA3 burst probability to recovery from burst-induced depression at recurrent collateral synapses. Journal of Neurophysiology. 86: 2736-47. PMID 11731533 DOI: 10.1152/Jn.2001.86.6.2736 |
0.551 |
|
| 1999 |
Hellier JL, Patrylo PR, Dou P, Nett M, Rose GM, Dudek FE. Assessment of inhibition and epileptiform activity in the septal dentate gyrus of freely behaving rats during the first week after kainate treatment. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 10053-64. PMID 10559413 DOI: 10.1523/Jneurosci.19-22-10053.1999 |
0.658 |
|
| 1999 |
Hellier JL, Dudek FE. Spontaneous motor seizures of rats with kainate-induced epilepsy: effect of time of day and activity state. Epilepsy Research. 35: 47-57. PMID 10232794 DOI: 10.1016/S0920-1211(98)00127-2 |
0.681 |
|
| 1998 |
Hellier JL, Patrylo PR, Buckmaster PS, Dudek FE. Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Research. 31: 73-84. PMID 9696302 DOI: 10.1016/S0920-1211(98)00017-5 |
0.737 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2010 |
Oliva AM, Salcedo E, Hellier JL, Ly X, Koka K, Tollin DJ, Restrepo D. Toward a mouse neuroethology in the laboratory environment. Plos One. 5: e11359. PMID 20613876 DOI: 10.1371/Journal.Pone.0011359 |
0.243 |
|
| 2012 |
Hellier JL, Arevalo NL, Smith L, Xiong KN, Restrepo D. α7-Nicotinic acetylcholine receptor: role in early odor learning preference in mice. Plos One. 7: e35251. PMID 22514723 DOI: 10.1371/Journal.Pone.0035251 |
0.085 |
|
| 2020 |
Hellier J, Emsley R, Pickles A. Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data. Trials. 21: 10. PMID 31900198 DOI: 10.1186/s13063-019-3810-9 |
0.083 |
|
| 2017 |
Absoud M, Brex P, Ciccarelli O, Diribe O, Giovannoni G, Hellier J, Howe R, Holland R, Kelly J, McCrone P, Murphy C, Palace J, Pickles A, Pike M, Robertson N, et al. A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE). Health Technology Assessment (Winchester, England). 21: 1-50. PMID 28639937 DOI: 10.3310/hta21310 |
0.083 |
|
| 2019 |
Strang J, Kelleher M, Mayet S, Day E, Hellier J, Byford S, Murphy C, McLennan B, Shearer J, Ryan E, Marsden J. Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT. Health Technology Assessment (Winchester, England). 23: 1-72. PMID 30702059 DOI: 10.3310/hta23030 |
0.077 |
|
| 2016 |
Marsden J, Stillwell G, Hellier J, Brown AM, Byford S, Kelleher M, Kelly J, Murphy C, Shearer J, Mitcheson L. Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial. Contemporary Clinical Trials. PMID 27940188 DOI: 10.1016/j.cct.2016.12.003 |
0.072 |
|
| 2011 |
Mann E, Smith M, Hellier J, Hunter MS. A randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): trial protocol. Bmc Cancer. 11: 44. PMID 21281461 DOI: 10.1186/1471-2407-11-44 |
0.066 |
|
| 2011 |
Stachulski AV, Pidathala C, Row EC, Sharma R, Berry NG, Iqbal M, Bentley J, Allman SA, Edwards G, Helm A, Hellier J, Korba BE, Semple JE, Rossignol JF. Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication. Journal of Medicinal Chemistry. 54: 4119-32. PMID 21553812 DOI: 10.1021/Jm200153P |
0.065 |
|
| 2010 |
Hellier JL, Arevalo NL, Blatner MJ, Dang AK, Clevenger AC, Adams CE, Restrepo D. Olfactory discrimination varies in mice with different levels of α7-nicotinic acetylcholine receptor expression. Brain Research. 1358: 140-50. PMID 20713028 DOI: 10.1016/J.Brainres.2010.08.027 |
0.061 |
|
| 2019 |
Marsden J, Stillwell G, James K, Shearer J, Byford S, Hellier J, Kelleher M, Kelly J, Murphy C, Mitcheson L. Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial. The Lancet. Psychiatry. PMID 30952568 DOI: 10.1016/S2215-0366(19)30097-5 |
0.06 |
|
| 2011 |
Stachulski AV, Pidathala C, Row EC, Sharma R, Berry NG, Lawrenson AS, Moores SL, Iqbal M, Bentley J, Allman SA, Edwards G, Helm A, Hellier J, Korba BE, Semple JE, et al. Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication. Journal of Medicinal Chemistry. 54: 8670-80. PMID 22059983 DOI: 10.1021/jm201264t |
0.059 |
|
| 2015 |
Metrebian N, Groshkova T, Hellier J, Charles V, Martin A, Forzisi L, Lintzeris N, Zador D, Williams H, Carnwath T, Mayet S, Strang J. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT). Addiction (Abingdon, England). 110: 479-90. PMID 25251885 DOI: 10.1111/add.12748 |
0.058 |
|
| 2011 |
Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet (London, England). 378: 403-11. PMID 21764118 DOI: 10.1016/S0140-6736(11)60830-1 |
0.058 |
|
| 2014 |
Weaver T, Metrebian N, Hellier J, Pilling S, Charles V, Little N, Poovendran D, Mitcheson L, Ryan F, Bowden-Jones O, Dunn J, Glasper A, Finch E, Strang J. Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. Lancet (London, England). 384: 153-63. PMID 24725468 DOI: 10.1016/S0140-6736(14)60196-3 |
0.056 |
|
| 2012 |
Mann E, Smith MJ, Hellier J, Balabanovic JA, Hamed H, Grunfeld EA, Hunter MS. Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial. The Lancet. Oncology. 13: 309-18. PMID 22340966 DOI: 10.1016/S1470-2045(11)70364-3 |
0.053 |
|
| 2021 |
Metrebian N, Weaver T, Goldsmith K, Pilling S, Hellier J, Pickles A, Shearer J, Byford S, Mitcheson L, Bijral P, Bogdan N, Bowden-Jones O, Day E, Dunn J, Glasper A, et al. Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial. Bmj Open. 11: e046371. PMID 34210725 DOI: 10.1136/bmjopen-2020-046371 |
0.048 |
|
| 2016 |
Robinson P, Hellier J, Barrett B, Barzdaitiene D, Bateman A, Bogaardt A, Clare A, Somers N, O'Callaghan A, Goldsmith K, Kern N, Schmidt U, Morando S, Ouellet-Courtois C, Roberts A, et al. The NOURISHED randomised controlled trial comparing mentalisation-based treatment for eating disorders (MBT-ED) with specialist supportive clinical management (SSCM-ED) for patients with eating disorders and symptoms of borderline personality disorder. Trials. 17: 549. PMID 27855714 DOI: 10.1186/S13063-016-1606-8 |
0.047 |
|
| 2016 |
Rafia R, Dodd PJ, Brennan A, Meier PS, Hope VD, Ncube F, Byford S, Tie H, Metrebian N, Hellier J, Weaver T, Strang J. An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence. Addiction (Abingdon, England). PMID 26990598 DOI: 10.1111/add.13385 |
0.046 |
|
| 2013 |
Romeo R, Knapp M, Hellier J, Dewey M, Ballard C, Baldwin R, Bentham P, Burns A, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, et al. Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial. The British Journal of Psychiatry : the Journal of Mental Science. 202: 121-8. PMID 23258767 DOI: 10.1192/Bjp.Bp.112.115212 |
0.04 |
|
| 2016 |
Pickles A, Sharp H, Hellier J, Hill J. Prenatal anxiety, maternal stroking in infancy, and symptoms of emotional and behavioral disorders at 3.5 years. European Child & Adolescent Psychiatry. PMID 27464490 DOI: 10.1007/s00787-016-0886-6 |
0.038 |
|
| 2019 |
Zuidersma M, Chua KC, Hellier J, Voshaar RO, Banerjee S. Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 31084994 DOI: 10.1016/j.jagp.2019.03.021 |
0.036 |
|
| 2012 |
Ayers B, Smith M, Hellier J, Mann E, Hunter MS. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause (New York, N.Y.). 19: 749-59. PMID 22336748 DOI: 10.1097/gme.0b013e31823fe835 |
0.033 |
|
| 2014 |
Robinson P, Barrett B, Bateman A, Hakeem A, Hellier J, Lemonsky F, Rutterford C, Schmidt U, Fonagy P. Study Protocol for a randomized controlled trial of mentalization based therapy against specialist supportive clinical management in patients with both eating disorders and symptoms of borderline personality disorder. Bmc Psychiatry. 14: 51. PMID 24555511 DOI: 10.1186/1471-244X-14-51 |
0.032 |
|
| 1979 |
Hellier JL, Goldstein H. The use of birthweight and gestation to assess perinatal mortality risk. Journal of Epidemiology and Community Health. 33: 183-5. PMID 508997 |
0.01 |
|
| Hide low-probability matches. |